10/10
08:15 am
cmnd
Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site [Yahoo! Finance]
Medium
Report
Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site [Yahoo! Finance]
10/10
08:07 am
cmnd
Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site
Low
Report
Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site
9/16
04:10 pm
cmnd
Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy [Yahoo! Finance]
Low
Report
Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy [Yahoo! Finance]
9/16
04:06 pm
cmnd
Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy
Low
Report
Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy
9/12
08:20 am
cmnd
Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment
Medium
Report
Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment
9/6
07:55 am
cmnd
Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
Low
Report
Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
8/29
04:38 pm
cmnd
SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination [Yahoo! Finance]
Medium
Report
SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination [Yahoo! Finance]
8/29
04:25 pm
cmnd
Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment
Medium
Report
Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment
11/20
04:01 pm
cmnd
Form 6-K Clearmind Medicine Inc. For: Nov 20
Low
Report
Form 6-K Clearmind Medicine Inc. For: Nov 20
11/14
05:09 pm
cmnd
Form SC 13G/A Clearmind Medicine Inc. Filed by: Iroquois Capital Management, LLC
Medium
Report
Form SC 13G/A Clearmind Medicine Inc. Filed by: Iroquois Capital Management, LLC
10/10
04:01 pm
cmnd
Form 6-K Clearmind Medicine Inc. For: Oct 10
Medium
Report
Form 6-K Clearmind Medicine Inc. For: Oct 10
10/1
06:04 am
cmnd
Form EFFECT Clearmind Medicine Inc.
Low
Report
Form EFFECT Clearmind Medicine Inc.
9/26
04:01 pm
cmnd
Form 6-K Clearmind Medicine Inc. For: Sep 26
Low
Report
Form 6-K Clearmind Medicine Inc. For: Sep 26
9/24
04:31 pm
cmnd
Form POS AM Clearmind Medicine Inc.
Low
Report
Form POS AM Clearmind Medicine Inc.
9/16
04:10 pm
cmnd
Form 6-K Clearmind Medicine Inc. For: Sep 16
Low
Report
Form 6-K Clearmind Medicine Inc. For: Sep 16
9/16
04:02 pm
cmnd
Form 6-K Clearmind Medicine Inc. For: Jul 31
Low
Report
Form 6-K Clearmind Medicine Inc. For: Jul 31
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register